154 related articles for article (PubMed ID: 36413835)
1. Evaluating the expression pattern of the opioid receptor in pituitary neuroendocrine tumors (PitNET) and the role of morphine and naloxone in the regulation of pituitary cell line growth and apoptosis.
Taghavi SF; Shahsavari Z; Adjaminezhad-Fard F; Ghorbani M; Ghorbanhosseini SS; Salimi V; Tavakoli-Yaraki M
Biomed Pharmacother; 2023 Jan; 157():114022. PubMed ID: 36413835
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mammalian MOR-1 gene expression after chronic treatment with morphine.
Prenus RV; Luscar E; Zhu ZP; Badisa RB; Goodman CB
Int J Mol Med; 2012 Dec; 30(6):1493-7. PubMed ID: 22992838
[TBL] [Abstract][Full Text] [Related]
3. The role of reactive oxygen species in morphine addiction of SH-SY5Y cells.
Ma J; Yuan X; Qu H; Zhang J; Wang D; Sun X; Zheng Q
Life Sci; 2015 Mar; 124():128-35. PubMed ID: 25623851
[TBL] [Abstract][Full Text] [Related]
4. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
Wang D; Raehal KM; Bilsky EJ; Sadée W
J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
[TBL] [Abstract][Full Text] [Related]
5. Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells.
Yu X; Mao X; Blake AD; Li WX; Chang SL
J Pharmacol Exp Ther; 2003 Aug; 306(2):447-54. PubMed ID: 12754318
[TBL] [Abstract][Full Text] [Related]
6. Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine.
Wang HY; Burns LH
PLoS One; 2009; 4(1):e4282. PubMed ID: 19172190
[TBL] [Abstract][Full Text] [Related]
7. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors.
Gil J; Marques-Pamies M; Valassi E; Serra G; Salinas I; Xifra G; Casano-Sancho P; Carrato C; Biagetti B; Sesmilo G; Marcos-Ruiz J; Rodriguez-Lloveras H; Rueda-Pujol A; Aulinas A; Blanco A; Hostalot C; Simó-Servat A; Muñoz F; Rico M; Ibáñez-Domínguez J; Cordero E; Webb SM; Jordà M; Puig-Domingo M
Front Endocrinol (Lausanne); 2023; 14():1129213. PubMed ID: 37033229
[TBL] [Abstract][Full Text] [Related]
10. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET).
Taghavi SF; Ghorbani M; Panahi M; Nazem S; Karimi M; Salimi V; Tavakoli-Yaraki M
Mol Biol Rep; 2023 Aug; 50(8):6425-6434. PubMed ID: 37326745
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line.
Gach K; Piestrzeniewicz M; Fichna J; Stefanska B; Szemraj J; Janecka A
Biochem Cell Biol; 2008 Jun; 86(3):217-26. PubMed ID: 18523482
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta-induced up-regulation of opioid receptors in the untreated and morphine-desensitized U87 MG human astrocytoma cells.
Byrne LS; Peng J; Sarkar S; Chang SL
J Neuroinflammation; 2012 Nov; 9():252. PubMed ID: 23164507
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis.
Huang N; Feng Y; Liu Y; Zhang Y; Liu L; Zhang B; Zhang T; Su Z; Xue L; Wu ZB
Int Immunopharmacol; 2024 Jun; 134():112159. PubMed ID: 38692018
[TBL] [Abstract][Full Text] [Related]
14. Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal.
Shoblock JR; Maidment NT
Neuroscience; 2007 Nov; 149(3):642-9. PubMed ID: 17905519
[TBL] [Abstract][Full Text] [Related]
15. Mu opioid receptors in the medial habenula contribute to naloxone aversion.
Boulos LJ; Ben Hamida S; Bailly J; Maitra M; Ehrlich AT; Gavériaux-Ruff C; Darcq E; Kieffer BL
Neuropsychopharmacology; 2020 Jan; 45(2):247-255. PubMed ID: 31005059
[TBL] [Abstract][Full Text] [Related]
16. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.
Torralva R; Eshleman AJ; Swanson TL; Schmachtenberg JL; Schutzer WE; Bloom SH; Wolfrum KM; Reed JF; Janowsky A
J Pharmacol Exp Ther; 2020 Sep; 374(3):376-391. PubMed ID: 32513839
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment.
Wu Q; Hwang CK; Zheng H; Wagley Y; Lin HY; Kim DK; Law PY; Loh HH; Wei LN
FASEB J; 2013 Feb; 27(2):522-35. PubMed ID: 23085997
[TBL] [Abstract][Full Text] [Related]
19. Opioid antagonist-induced regulation of the mu-opioid receptor expression in MCF-7 breast cancer cell line.
Gach K; Piestrzeniewicz M; Fichna J; Szemraj J; Janecka A
Endocr Regul; 2009 Jan; 43(1):23-8. PubMed ID: 19309235
[TBL] [Abstract][Full Text] [Related]
20. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
